PDB: 9760 resultsInfo pagesStatus searchChemie searchBIRD

---

8SJK	Pembrolizumab Caffeine crystal Descriptor: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, ANTIBODY HEAVY CHAIN, ANTIBODY LIGHT CHAIN, ... Authors: Larpent, P, Codan, L, Bothe, J.R, Stueber, D, Reichert, P, Fischmann, T, Su, Y, Pabit, S, Gupta, S, Iuzzolino, L, Cote, A. Deposit date: 2023-04-18 Release date: 2024-04-24 Last modified: 2024-07-17 Method: X-RAY DIFFRACTION (2.22 Å) Cite: Small-Angle X-ray Scattering as a Powerful Tool for Phase and Crystallinity Assessment of Monoclonal Antibody Crystallites in Support of Batch Crystallization. Mol Pharm., 2024
6XCA	Crystal structure of an anti-SARS-CoV-2 human neutralizing antibody Fab fragment, C105 Descriptor: C105 Heavy Chain, C105 Light Chain, SULFATE ION Authors: Sharaf, N.G, Barnes, C.O, Bjorkman, P.J. Deposit date: 2020-06-08 Release date: 2020-07-01 Last modified: 2023-10-18 Method: X-RAY DIFFRACTION (1.8 Å) Cite: Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies. Cell, 182, 2020
7JMX	Crystal structure of a SARS-CoV-2 cross-neutralizing antibody COVA1-16 Fab Descriptor: ACETATE ION, COVA1-16 heavy chain, COVA1-16 light chain, ... Authors: Liu, H, Yuan, M, Zhu, X, Wu, N.C, Wilson, I.A. Deposit date: 2020-08-03 Release date: 2020-10-14 Last modified: 2023-10-18 Method: X-RAY DIFFRACTION (2.53 Å) Cite: Cross-Neutralization of a SARS-CoV-2 Antibody to a Functionally Conserved Site Is Mediated by Avidity. Immunity, 53, 2020
6B5N	Structure of PfCSP peptide 25 with human protective antibody CIS43 Descriptor: CIS43 Fab Heavy chain, CIS43 Fab Light chain, pfCSP peptide 25: ASN-VAL-ASP-PRO-ASN-ALA-ASN-PRO-ASN-VAL-ASP Authors: Pancera, M, Weidle, C. Deposit date: 2017-09-29 Release date: 2018-03-21 Last modified: 2018-04-25 Method: X-RAY DIFFRACTION (1.98 Å) Cite: A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasite. Nat. Med., 24, 2018
1YED	STRUCTURE OF A CATALYTIC ANTIBODY IGG2A FAB FRAGMENT (D2.4) Descriptor: 4-NITRO-BENZYLPHOSPHONOBUTANOYL-GLYCINE, IGG1 FAB FRAGMENT (D.2.4) Authors: Golinelli-Pimpaneau, B, Knossow, M. Deposit date: 1997-04-15 Release date: 1997-10-15 Last modified: 2023-08-09 Method: X-RAY DIFFRACTION (3.1 Å) Cite: Structural convergence in the active sites of a family of catalytic antibodies. Science, 275, 1997
1YEE	STRUCTURE OF A CATALYTIC ANTIBODY, IGG2A FAB FRAGMENT (D2.5) Descriptor: 4-NITRO-BENZYLPHOSPHONOBUTANOYL-GLYCINE, IGG2A FAB FRAGMENT (D2.5) Authors: Golinelli-Pimpaneau, B, Knossow, M. Deposit date: 1997-04-15 Release date: 1997-10-15 Last modified: 2023-08-09 Method: X-RAY DIFFRACTION (2.2 Å) Cite: Structural convergence in the active sites of a family of catalytic antibodies. Science, 275, 1997
7JMW	Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with cross-neutralizing antibody COVA1-16 Fab Descriptor: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, COVA1-16 heavy chain, COVA1-16 light chain, ... Authors: Liu, H, Yuan, M, Zhu, X, Wu, N.C, Wilson, I.A. Deposit date: 2020-08-03 Release date: 2020-10-14 Last modified: 2023-10-18 Method: X-RAY DIFFRACTION (2.89 Å) Cite: Cross-Neutralization of a SARS-CoV-2 Antibody to a Functionally Conserved Site Is Mediated by Avidity. Immunity, 53, 2020
2YMX	Crystal structure of inhibitory anti-AChE Fab408 Descriptor: FAB ANTIBODY HEAVY CHAIN, FAB ANTIBODY LIGHT CHAIN, GLYCEROL Authors: Bourne, Y, Renault, L, Essono, S, Mondielli, G, Lamourette, P, Bocquet, D, Grassi, J, Marchot, P. Deposit date: 2012-10-10 Release date: 2013-10-23 Last modified: 2023-12-20 Method: X-RAY DIFFRACTION (1.9 Å) Cite: Molecular Characterization of Monoclonal Antibodies that Inhibit Acetylcholinesterase by Targeting the Peripheral Site and Backdoor Region Plos One, 8, 2013
7E3O	Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody nCoV617 Descriptor: Spike protein S1, nCoV617 Heigh Chain, nCoV617 Light Chain Authors: Chen, S.D, Yang, M. Deposit date: 2021-02-09 Release date: 2021-09-15 Last modified: 2023-11-29 Method: X-RAY DIFFRACTION (2.51 Å) Cite: Structural Basis of a Human Neutralizing Antibody Specific to the SARS-CoV-2 Spike Protein Receptor-Binding Domain. Microbiol Spectr, 9, 2021
3PP4	Epitope characterization and crystal structure of GA101 provide insights into the molecular basis for the type I / type II distinction of anti- CD20 antibodies Descriptor: B-lymphocyte antigen CD20, CHLORIDE ION, GA101 Fab heavy chain, ... Authors: Hopfner, K.-P, Lammens, A. Deposit date: 2010-11-24 Release date: 2011-04-13 Last modified: 2023-09-06 Method: X-RAY DIFFRACTION (1.6 Å) Cite: Epitope characterization and crystal structure of GA101 provide insights into the molecular basis for type I/II distinction of CD20 antibodies. Blood, 118, 2011
3PP3	Epitope characterization and crystal structure of GA101 provide insights into the molecular basis for the type I / type II distinction of anti- CD20 antibodies Descriptor: GA101 Fab heavy chain, GA101 Fab light chain Authors: Hopfner, K.-P, Lammens, A. Deposit date: 2010-11-24 Release date: 2011-04-13 Last modified: 2023-09-06 Method: X-RAY DIFFRACTION (2.508 Å) Cite: Epitope characterization and crystal structure of GA101 provide insights into the molecular basis for type I/II distinction of CD20 antibodies. Blood, 118, 2011
1YEC	STRUCTURE OF A CATALYTIC ANTIBODY IGG2A FAB FRAGMENT (D2.3) Descriptor: 4-NITRO-BENZYLPHOSPHONOBUTANOYL-GLYCINE, IGG2A FAB FRAGMENT (D2.3), ZINC ION Authors: Golinelli-Pimpaneau, B, Knossow, M. Deposit date: 1997-04-15 Release date: 1997-10-15 Last modified: 2023-08-09 Method: X-RAY DIFFRACTION (1.9 Å) Cite: Structural convergence in the active sites of a family of catalytic antibodies. Science, 275, 1997
6B5M	Structure of PfCSP peptide 21 with human protective antibody CIS43 Descriptor: 1,2-ETHANEDIOL, CIS43 Fab Heavy chain, CIS43 Fab Light chain, ... Authors: Pancera, M, Weidle, C. Deposit date: 2017-09-29 Release date: 2018-03-21 Last modified: 2018-04-25 Method: X-RAY DIFFRACTION (1.79 Å) Cite: A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasite. Nat. Med., 24, 2018
5VGP	Fc fragment of human IgG1 antibody, from NIST mAb Descriptor: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, Human Fc fragment with G1F/G0F glycan, beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alpha-D-mannopyranose-(1-6)-[2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alpha-D-mannopyranose-(1-3)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Authors: Gallagher, D.T, Galvin, C.V, Karageorgos, I, Marino, J.P. Deposit date: 2017-04-11 Release date: 2018-04-18 Last modified: 2023-10-04 Method: X-RAY DIFFRACTION (2.116 Å) Cite: Structure of the Fc fragment of the NIST reference antibody RM8671. Acta Crystallogr F Struct Biol Commun, 74, 2018
6CXC	3.9A Cryo-EM structure of murine antibody bound at a novel epitope of respiratory syncytial virus fusion protein Descriptor: 2-acetamido-2-deoxy-beta-D-glucopyranose, Fusion glycoprotein F0, Envelope glycoprotein chimera, ... Authors: Xie, Q, Wang, Z, Chen, X, Ni, F, Ma, J, Wang, Q. Deposit date: 2018-04-02 Release date: 2019-07-31 Last modified: 2020-07-29 Method: ELECTRON MICROSCOPY (3.9 Å) Cite: Structure basis of neutralization by a novel site II/IV antibody against respiratory syncytial virus fusion protein. Plos One, 14, 2019
6DC7	Apo Fab structure of mouse monoclonal antibody 8B2 Descriptor: Fab heavy chain, Fab light chain Authors: Chukwu, J.E, Kong, X.-P. Deposit date: 2018-05-04 Release date: 2019-03-20 Last modified: 2019-12-18 Method: X-RAY DIFFRACTION (1.901 Å) Cite: Structural characterization of monoclonal antibodies targeting C-terminal Ser404region of phosphorylated tau protein. MAbs, 11, 2019
6DCA	Fab/epitope complex of mouse monoclonal antibody 6B2 targeting a non-phosphorylated tau epitope. Descriptor: Fab heavy chain, Fab light chain, Microtubule-associated protein tau, ... Authors: Chukwu, J.E, Kong, X.-P. Deposit date: 2018-05-04 Release date: 2019-03-20 Last modified: 2019-12-18 Method: X-RAY DIFFRACTION (2.599 Å) Cite: Structural characterization of monoclonal antibodies targeting C-terminal Ser404region of phosphorylated tau protein. MAbs, 11, 2019
6DC9	Fab/epitope complex of human chimeric monoclonal antibody h4E6 targeting a phosphorylated tau epitope. Descriptor: Fab heavy chain, Fab light chain, GLYCEROL, ... Authors: Chukwu, J.E, Kong, X.-P. Deposit date: 2018-05-04 Release date: 2019-03-20 Last modified: 2019-12-18 Method: X-RAY DIFFRACTION (2.999 Å) Cite: Structural characterization of monoclonal antibodies targeting C-terminal Ser404region of phosphorylated tau protein. MAbs, 11, 2019
6DC8	Fab/epitope complex of mouse monoclonal antibody 8B2 targeting a non-phosphorylated tau epitope. Descriptor: GLYCEROL, IgG heavy chain, IgG light chain, ... Authors: Chukwu, J.E, Kong, X.-P. Deposit date: 2018-05-04 Release date: 2019-03-20 Last modified: 2019-12-18 Method: X-RAY DIFFRACTION (1.799 Å) Cite: Structural characterization of monoclonal antibodies targeting C-terminal Ser404region of phosphorylated tau protein. MAbs, 11, 2019
6UM5	Cryo-EM structure of HIV-1 neutralizing antibody DH270 UCA3 in complex with CH848 10.17DT Env Descriptor: 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, ... Authors: Acharya, P, Henderson, R.C, Saunders, K.O, Haynes, B.F. Deposit date: 2019-10-09 Release date: 2019-12-18 Last modified: 2020-07-29 Method: ELECTRON MICROSCOPY (4.2 Å) Cite: Targeted selection of HIV-specific antibody mutations by engineering B cell maturation. Science, 366, 2019
7R40	Structure of the SARS-CoV-2 spike glycoprotein in complex with the 87G7 antibody Fab fragment Descriptor: 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, 87G7 heavy chain variable region, ... Authors: Hurdiss, D.L. Deposit date: 2022-02-08 Release date: 2022-04-20 Last modified: 2023-12-13 Method: ELECTRON MICROSCOPY (2.9 Å) Cite: An ACE2-blocking antibody confers broad neutralization and protection against Omicron and other SARS-CoV-2 variants of concern. Sci Immunol, 7, 2022
4PLJ	Hepatitis E Virus E2s domain (Genotype IV) in complex with a neutralizing antibody 8G12 Descriptor: 8G12 heavy chain, 8G12 light chain, Capsid protein Authors: Tang, X.H, Li, S.W, Sivaraman, J. Deposit date: 2014-05-18 Release date: 2015-04-15 Last modified: 2015-05-13 Method: X-RAY DIFFRACTION (2.3 Å) Cite: Structural basis for the neutralization of hepatitis E virus by a cross-genotype antibody Cell Res., 25, 2015
5I0Z	Crystal structure of the single domain catalytic antibody 3D8-VH Descriptor: catalytic DNA antibody Authors: Park, S.Y, Kim, J.S. Deposit date: 2016-02-04 Release date: 2016-02-24 Last modified: 2023-11-08 Method: X-RAY DIFFRACTION (1.9 Å) Cite: Crystal structure of the single domain catalytic antibody 3D8-VH To Be Published
6UM7	Cryo-EM structure of vaccine-elicited HIV-1 neutralizing antibody DH270.mu1 in complex with CH848 10.17DT Env Descriptor: 2-acetamido-2-deoxy-beta-D-glucopyranose, DH270.mu1 Fab Heavy Chain, DH270.mu1 Fab Light chain, ... Authors: Acharya, P, Henderson, R.C, Saunders, K, Haynes, B.F. Deposit date: 2019-10-09 Release date: 2019-12-18 Last modified: 2020-07-29 Method: ELECTRON MICROSCOPY (3.5 Å) Cite: Targeted selection of HIV-specific antibody mutations by engineering B cell maturation. Science, 366, 2019
8DPM	Structure of EBOV GP lacking the mucin-like domain with 9.20.1A2 Fab and 6D6 scFv bound Descriptor: 2-acetamido-2-deoxy-beta-D-glucopyranose, Antibody 6D6 scFv, Antibody 9.20.1A2 Fab heavy chain, ... Authors: Yu, X, Saphire, E.O. Deposit date: 2022-07-15 Release date: 2023-07-19 Last modified: 2023-11-22 Method: ELECTRON MICROSCOPY (3 Å) Cite: The evolution and determinants of neutralization of potent head-binding antibodies against Ebola virus. Cell Rep, 42, 2023

<77787980818283848586878889909192>